BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33012711)

  • 1. Simultaneous bilateral aqueous misdirection following certolizumab therapy for rheumatoid arthritis.
    Hynnekleiv L; Thrane AS; Krohn J
    BMJ Case Rep; 2020 Oct; 13(10):. PubMed ID: 33012711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anaphylactic reaction by certolizumab in young woman with rheumatoid arthritis].
    Caballero-Requejo C; Monteagudo-González L; Urbieta-Sanz E
    Farm Hosp; 2018 May; 42(3):135-136. PubMed ID: 29730985
    [No Abstract]   [Full Text] [Related]  

  • 3. Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.
    Ruiz Garcia V; Burls A; Cabello JB; Vela Casasempere P; Bort-Marti S; Bernal JA
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD007649. PubMed ID: 28884785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Miller Fisher syndrome following treatment with certolizumab in a patient with rheumatoid arthritis].
    Alberola-Amores FJ; Navarro-Canto L; Gonzalez-Ferrandez JA
    Rev Neurol; 2017 Sep; 65(6):286-288. PubMed ID: 28896005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Case of Minimal Change Disease in a Patient with Rheumatoid Arthritis Treated with Certolizumab.
    Hwang SR; Sawatsky AP
    J Rheumatol; 2019 Dec; 46(12):1647. PubMed ID: 31676702
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful recovery from misdirection syndrome in nanophthalmic eyes by performing an anterior vitrectomy through the anterior chamber.
    Faisal AA; Kamaruddin MI; Toda R; Kiuchi Y
    Int Ophthalmol; 2019 Feb; 39(2):347-357. PubMed ID: 29299722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitrectomy-phacoemulsification-vitrectomy for the management of aqueous misdirection syndromes in phakic eyes.
    Sharma A; Sii F; Shah P; Kirkby GR
    Ophthalmology; 2006 Nov; 113(11):1968-73. PubMed ID: 17074562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Certolizumab Pegol: A Review in Inflammatory Autoimmune Diseases.
    Deeks ED
    BioDrugs; 2016 Dec; 30(6):607-617. PubMed ID: 27704400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and chronic fluid misdirection syndrome: pathophysiology and treatment.
    Grzybowski A; Kanclerz P
    Graefes Arch Clin Exp Ophthalmol; 2018 Jan; 256(1):135-154. PubMed ID: 29110086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute exacerbation of rheumatoid interstitial lung disease during the maintenance therapy with certolizumab pegol.
    Migita K; Tsuji Y; Hisatomi K; Shigeno R; Izumi Y; Iwanaga N; Koga T
    Mod Rheumatol; 2017 Nov; 27(6):1079-1082. PubMed ID: 26044288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of hypocomplementemic urticarial vasculitis during certolizumab pegol treatment for rheumatoid arthritis: A case report.
    Horai Y; Ishikawa H; Iwanaga N; Izumi Y; Matsuoka Y; Miura S; Kawakami A
    J Clin Pharm Ther; 2020 Oct; 45(5):1179-1182. PubMed ID: 31990069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-utility analysis of certolizumab pegol in combination with methotrexate in patients with moderate-to-severe active rheumatoid arthritis in Greece.
    Tzanetakos C; Tzioufas A; Goules A; Kourlaba G; Theodoratou T; Christou P; Maniadakis N
    Rheumatol Int; 2017 Sep; 37(9):1441-1452. PubMed ID: 28523420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Certolizumab pegol plus methotrexate 5-year results from the rheumatoid arthritis prevention of structural damage (RAPID) 2 randomized controlled trial and long-term extension in rheumatoid arthritis patients.
    Smolen JS; van Vollenhoven R; Kavanaugh A; Strand V; Vencovsky J; Schiff M; Landewé R; Haraoui B; Arendt C; Mountian I; Carter D; van der Heijde D
    Arthritis Res Ther; 2015 Sep; 17(1):245. PubMed ID: 26353833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypotonous malignant glaucoma: aqueous misdirection with low intraocular pressure.
    Burgansky-Eliash Z; Ishikawa H; Schuman JS
    Ophthalmic Surg Lasers Imaging; 2008; 39(2):155-9. PubMed ID: 18435344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Approaches in Tumor Necrosis Factor Antagonism for the Treatment of Psoriatic Arthritis: Certolizumab Pegol.
    Cauli A; Piga M; Lubrano E; Marchesoni A; Floris A; Mathieu A
    J Rheumatol Suppl; 2015 Nov; 93():70-2. PubMed ID: 26523062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slit-lamp needle revision for aqueous misdirection after trabeculectomy.
    Francis BA; Wong RM; Minckler DS
    J Glaucoma; 2002 Jun; 11(3):183-8. PubMed ID: 12140393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling of the clinical and economic impact of a risk-sharing agreement supporting a treat-to-target strategy in the management of patients with rheumatoid arthritis in France.
    Fagnani F; Pham T; Claudepierre P; Berenbaum F; De Chalus T; Saadoun C; Joubert JM; Fautrel B
    J Med Econ; 2016 Aug; 19(8):812-21. PubMed ID: 27065315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aqueous misdirection after glaucoma drainage device implantation.
    Greenfield DS; Tello C; Budenz DL; Liebmann JM; Ritch R
    Ophthalmology; 1999 May; 106(5):1035-40. PubMed ID: 10328410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-year risk of serious infection in patients treated with certolizumab pegol as compared with other TNF inhibitors in a real-world setting: data from a national U.S. rheumatoid arthritis registry.
    Harrold LR; Litman HJ; Saunders KC; Dandreo KJ; Gershenson B; Greenberg JD; Low R; Stark J; Suruki R; Jaganathan S; Kremer JM; Yassine M
    Arthritis Res Ther; 2018 Jan; 20(1):2. PubMed ID: 29329557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serious infection across biologic-treated patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
    Rutherford AI; Subesinghe S; Hyrich KL; Galloway JB
    Ann Rheum Dis; 2018 Jun; 77(6):905-910. PubMed ID: 29592917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.